ESR1 and colorectal carcinoma: But how does this work in CRC and what are the factors that determine whether oestrogen will exert a protective or exacerbating role via Wnt/β-catenin pathway signalling in CRC, in particular when the expression of ER is lost with advancing tumorigenesis?